ApprovalTrail

Medical device licence · 9156 · Class 2

REOVIRUS CF ANTIGEN

No longer licensed: discontinued at renewal

Licence status Discontinued at renewal; first licensed July 29, 1999; ended October 29, 2003. It is in Health Canada’s archive of licences no longer in force.
Licence number
9156
Licence holder
Cambrex Bioscience Walkersville, Inc.Walkersville, MD, United States
Risk class
Class II (low to moderate risk)
Licence type
Single Device
First licensed
July 29, 1999
Ended
October 29, 2003
Devices covered
1

Devices on this licence

By name, as listed. The official record lists model numbers and identifiers.

  • REOVIRUS CF ANTIGEN

Class I devices, the lowest-risk group, mostly need no device licence, so most are not in this list.